BAY COLONY ADVISORY GROUP, INC D/B/A BAY COLONY ADVISORS – Regeneron Pharmaceuticals, Inc. Transaction History
BAY COLONY ADVISORY GROUP, INC D/B/A BAY COLONY ADVISORS portfolio value:
$1.53M
portfolio value
BAY COLONY ADVISORY GROUP, INC D/B/A BAY COLONY ADVISORS quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -0.45% | -10 shares | 233K | $688.87 | 2.22K |
Q2 2022 | share | Decrease | -16.50% | -442 shares | -570K | $591.13 | 2.23K |
Q1 2022 | share | Decrease | -8.32% | -243 shares | 26K | $698.42 | 2.67K |
Q4 2021 | share | Increase | +4.10% | 115 shares | 146K | $642.51 | 2.92K |
Q3 2021 | share | Increase | +16.28% | 393 shares | 351K | $605.18 | 2.80K |
Q2 2021 | share | Decrease | -0.12% | -3 shares | 204K | $558.54 | 2.41K |
Q1 2021 | share | Increase | +53.46% | 842 shares | 383K | $473.14 | 2.41K |
Q4 2020 | share | Increase | +39.88% | 449 shares | 131K | $483.11 | 1.57K |
Q3 2020 | share | Increase | 0.00% | 1.12K shares | 630K | $559.78 | 1.12K |
Q1 2020 | share | Decrease | -100.00% | -693 shares | -249K | $488.29 | 0 |
Q4 2019 | share | Increase | 0.00% | 693 shares | 249K | $375.48 | 693 |